KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-Current Debt (2018 - 2025)

Twist Bioscience (TWST) has disclosed Non-Current Debt for 3 consecutive years, with $625000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Non-Current Debt fell 82.97% to $625000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $625000.0, a 82.97% decrease, with the full-year FY2020 number at $1.4 million, down 68.11% from a year prior.
  • Non-Current Debt was $625000.0 for Q4 2020 at Twist Bioscience, down from $1.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $7.2 million in Q3 2018 to a low of $625000.0 in Q4 2020.
  • A 3-year average of $4.0 million and a median of $4.0 million in 2019 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: tumbled 39.04% in 2019, then plummeted 82.97% in 2020.
  • Twist Bioscience's Non-Current Debt stood at $6.5 million in 2018, then crashed by 43.78% to $3.7 million in 2019, then tumbled by 82.97% to $625000.0 in 2020.
  • Per Business Quant, the three most recent readings for TWST's Non-Current Debt are $625000.0 (Q4 2020), $1.4 million (Q3 2020), and $2.2 million (Q2 2020).